Bank of New York Mellon Corp lessened its stake in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 4.2% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 203,116 shares of the company’s stock a…